About Nephron Pharmaceuticals
Nephron Pharmaceuticals is a Healthcare company based in Florida (United States) founded in 1937. Sterile pharmaceutical products are manufactured and contract services are provided. Nephron Pharmaceuticals has raised $625 million across 5 funding rounds from investors including PNC, Blackrockbkcc and WhiteHawk Capital Partners. Its website nephronpharm.com draws about 14 thousand monthly visits. Nephron Pharmaceuticals offers products and services including Inhalation Products, 503B Outsourcing, and Contract Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development. Its legal entity is Nephron Pharmaceuticals Corporation.
Company details
Nephron Pharmaceuticals was founded in 1937 and operates in the pharmaceutical sector, focusing on sterile products. Generic respiratory medications are produced, along with pre-filled sterile options to address drug shortages. Contract manufacturing and 503B outsourcing services are offered, covering development, production, and packaging in facilities located in Florida and Puerto Rico. Community initiatives and educational programs in pharmacy and healthcare are supported.
- Headquarters Florida, United States
- SectorsHealthcare
- Website category Health · Pharmacy
- Website nephronpharm.com
- Social LinkedIn X Facebook YouTube
- Legal Name Nephron Pharmaceuticals Corporation
- Total Equity Funding$625M (USD)
in 5 rounds
- InvestorsPNC
& 3 more
Products & Services of Nephron Pharmaceuticals
Nephron Pharmaceuticals offers a comprehensive portfolio of products and services, including Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
Develops and manufactures solutions for respiratory ailments like asthma and COPD.
Provides sterile pre-filled medications to address shortages in hospitals.
Offers sterile medication production for medical facilities across America.
Apps and channels of Nephron Pharmaceuticals
its YouTube channel Nephron TV has 42 subscribers and 30 videos.
Videos from Nephron Pharmaceuticals
The most watched videos on Nephron Pharmaceuticals's YouTube channel, Nephron TV (42 subscribers). Click a video to play it here.
More on Nephron TV.
Funding Insights of Nephron Pharmaceuticals
Nephron Pharmaceuticals has successfully raised a total of $625M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $625M
- Total Rounds 5
- First Round $275M
(Aug 2014)
- Investors Count 4
All 5 funding rounds of Nephron Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | Debt – Conventional | – | – | ||
| Sep 2023 | $350M | Private Equity Round | – | Blackrockbkcc, PNC | – |
| Aug 2017 | $330M | Debt – Conventional | – | – | |
| Aug 2014 | $75M | Debt – Conventional | – | – | – |
| Aug 2014 | $275M | Private Equity Round | – | – | – |
4 investors in total: 4 institutional.
Investors in Nephron Pharmaceuticals
Nephron Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include PNC, Blackrockbkcc and WhiteHawk Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage technology investments are made by TCP Venture Capital. | tcp.vc | Baltimore, United States | ||
Provides asset-based financing solutions to middle market private and public companies. | 2020 | whitehawkcapital.com | Los Angeles, United States | |
Blackrockbkcc is maintained as a web-based entity. | blackrockbkcc.gcs-web.com | |||
Commercial banking and financing services are provided by PNC. | 1845 | pnc.com | Pittsburgh, United States |
Investor details for Nephron Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nephron Pharmaceuticals
3 dated milestones of Nephron Pharmaceuticals across 88 years, from founding to its latest funding, stage changes and deals.
- Founded Nephron Pharmaceuticals is founded.
- Funding First funding round of $275.0M.
- Funding Latest funding round, Debt – Conventional,.
Web traffic of Nephron Pharmaceuticals
The website of Nephron Pharmaceuticals (nephronpharm.com) receives about 14K visits a month and ranks #2,507,462 among all websites worldwide, #3,274 in Pharmacy.
- Monthly visits14K
▲ 59.6% vs previous month
- Unique visitors4.3K
per month
- Global rank#2,507,462
among all websites
- Category rank#3,274
Health · Pharmacy
- Bounce rate40%
- Pages per visit1.7
- Average visit15 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Nephron Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pharmacy180.com | pharmacy180.com | 100% | #592,831 | – | |
| pfizer.com | 95% | 1.9M | #24,984 | View details | |
| lilly.com | 84% | 4.9M | #13,252 | View details | |
shoestring-graphics.com | shoestring-graphics.com | 76% | – | ||
kidneyhealthcare.com | kidneyhealthcare.com | 74% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Nephron Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Nephron Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nephron Pharmaceuticals
Complete news archive for Nephron Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nephron Pharmaceuticals
Nephron Pharmaceuticals was founded in 1937 and raised its 1st funding round 77 years after it was founded.
Nephron Pharmaceuticals is headquartered in Florida, United States. It is registered at Florida, Puerto Rico, United States.
Nephron Pharmaceuticals is a funded company, having raised a total of $625M across 5 funding rounds to date. The company's 1st funding round was a Private Equity Round of $275M, raised on Aug 2014.
Nephron Pharmaceuticals was founded in 1937 and operates in the pharmaceutical sector, focusing on sterile products. Generic respiratory medications are produced, along with pre-filled sterile options to address drug shortages. Contract manufacturing and 503B outsourcing services are offered, covering development, production, and packaging in facilities located in Florida and Puerto Rico. Community initiatives and educational programs in pharmacy and healthcare are supported.
Nephron Pharmaceuticals offers Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
Nephron Pharmaceuticals has 4 investors. Key investors include PNC, Blackrockbkcc, WhiteHawk Capital Partners, and TCP Venture Capital.
Nephron Pharmaceuticals operates through Nephron Pharmaceuticals Corporation.